{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:28:12Z","timestamp":1791584892935,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T00:00:00Z","timestamp":1558137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10157-019-01744-3","type":"journal-article","created":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T10:56:46Z","timestamp":1558177006000},"page":"1050-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition"],"prefix":"10.1007","volume":"23","author":[{"given":"Nada M. Qamar","family":"El-Dawla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Aliaa M.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H.","family":"El-Hefnawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala O.","family":"El-Mesallamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,18]]},"reference":[{"key":"1744_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2011.183","volume":"8","author":"L Chen","year":"2011","unstructured":"Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives. Nat Rev Endocrinol. 2011;8:228\u201336.","journal-title":"Nat Rev Endocrinol."},{"key":"1744_CR2","first-page":"287","volume":"8","author":"MR Gaballa","year":"2013","unstructured":"Gaballa MR, Farag YMK. Predictors of diabetic nephropathy. Cent Eur J Med. 2013;8:287\u201396.","journal-title":"Cent Eur J Med."},{"key":"1744_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AKH Lim","year":"2014","unstructured":"Lim AKH. Diabetic nephropathy? Complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361\u201381.","journal-title":"Int J Nephrol Renovasc Dis."},{"key":"1744_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","volume":"6","author":"BM Leon","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015;6:1246\u201358.","journal-title":"World J Diabetes."},{"key":"1744_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semnephrol.2012.04.002","volume":"32","author":"HY Lan","year":"2012","unstructured":"Lan HY, Chung ACK. TGF-\u03b2\/Smad signaling in kidney disease. Semin Nephrol. 2012;32:236\u201343.","journal-title":"Semin Nephrol"},{"key":"1744_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semnephrol.2012.04.001","volume":"32","author":"L Gewin","year":"2012","unstructured":"Gewin L, Zent R. How does TGF? Mediate tubulointerstitial fibrosis? Semin Nephrol. 2012;32:228\u201335.","journal-title":"Semin Nephrol"},{"key":"1744_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4142\/jvs.2013.14.4.381","volume":"14","author":"S Lee","year":"2013","unstructured":"Lee S, Han SM, Kim J, Chung K, Han K. Science expression of E-cadherin in pig kidney. J Vet Sci. 2013;14:381\u20136.","journal-title":"J Vet Sci"},{"key":"1744_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1744_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.cub.2013.06.019","volume":"23","author":"J-L Ma\u00eetre","year":"2013","unstructured":"Ma\u00eetre J-L, Heisenberg C. Three functions of cadherins in cell adhesion. Curr Biol. 2013;23:626\u201333.","journal-title":"Curr Biol"},{"key":"1744_CR10","first-page":"3383","volume":"137","author":"RO Stephenson","year":"2010","unstructured":"Stephenson RO, Yamanaka Y, Rossant J. Disorganized epithelial polarity and excess trophectoderm cell fate in preimplantation embryos lacking E-cadherin. Dev Stem Cells. 2010;137:3383\u201391.","journal-title":"Dev Stem Cells."},{"key":"1744_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-015-0682-3","volume":"16","author":"R Chijimatsu","year":"2015","unstructured":"Chijimatsu R, Kunugiza Y, Taniyama Y, Nakamura N, Tomita T. Expression and pathological effects of periostin in human osteoarthritis cartilage. BMC Musculoskelet Disord. 2015;16:1\u201312.","journal-title":"BMC Musculoskelet Disord."},{"key":"1744_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbrc.2010.07.058","volume":"399","author":"M Takada","year":"2010","unstructured":"Takada M, Ban Y, Yamamoto G, Ueda T, Saito Y, Nishimura E. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy. Biochem Biophys Res Commun. 2010;399:221\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1744_CR13","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1093\/ndt\/gfr670","volume":"27","author":"B Satirapoj","year":"2012","unstructured":"Satirapoj B, Wang Y, Chamberlin MP, et al. Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells. Nephrol Dial Transplant. 2012;27:2702\u201311.","journal-title":"Nephrol Dial Transplant"},{"key":"1744_CR14","doi-asserted-by":"publisher","first-page":"e0124055","DOI":"10.1371\/journal.pone.0124055","volume":"10","author":"B Satirapoj","year":"2015","unstructured":"Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. PLoS One. 2015;10:e0124055.","journal-title":"PLoS One"},{"key":"1744_CR15","doi-asserted-by":"publisher","first-page":"156484","DOI":"10.1155\/2015\/156484","volume":"2015","author":"BW Teo","year":"2015","unstructured":"Teo BW, Loh PT, Wong WK, Ho PJ, Choi KP, Toh QC, et al. Spot\u00a0urine\u00a0estimations\u00a0are\u00a0equivalent\u00a0to\u00a024 hour\u00a0urine\u00a0assessments\u00a0of\u00a0urine protein\u00a0excretion\u00a0for\u00a0predicting\u00a0clinical\u00a0outcomes. Int J Nephrol. 2015;2015:156484. \n                    https:\/\/doi.org\/10.1155\/2015\/156484\n                    \n                  .","journal-title":"Int J Nephrol."},{"key":"1744_CR16","first-page":"8","volume":"2016","author":"A Zy\u0142ka","year":"2016","unstructured":"Zy\u0142ka A, Gala-B\u0142\u0105dzi\u0144ska A, Dumnicka P, et al. Is urinary NGAL determination useful for monitoring kidney function and assessment of cardiovascular disease? A 12-month observation of patients with type 2 diabetes. Dis Mark. 2016;2016:8.","journal-title":"Dis Mark"},{"key":"1744_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.clinbiochem.2015.10.016","volume":"49","author":"JAM de Carvalho","year":"2016","unstructured":"de Carvalho JAM, Tatsch E, Hausen BS, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes. Clin Biochem. 2016;49:232\u20136.","journal-title":"Clin Biochem"},{"key":"1744_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1681\/ASN.2008121226","volume":"21","author":"Y Liu","year":"2010","unstructured":"Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010;21:212\u201322.","journal-title":"J Am Soc Nephrol"},{"key":"1744_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","volume":"17","author":"J He","year":"2013","unstructured":"He J, Xu Y, Koya D, Kanasaki K. Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol. 2013;17:488\u201397.","journal-title":"Clin Exp Nephrol"},{"key":"1744_CR20","doi-asserted-by":"publisher","first-page":"20202","DOI":"10.1074\/jbc.M110.102012","volume":"285","author":"SN Flier","year":"2010","unstructured":"Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem. 2010;285:20202\u201312.","journal-title":"J Biol Chem"},{"key":"1744_CR21","first-page":"18","volume":"8","author":"MR Rizvi","year":"2016","unstructured":"Rizvi MR, Rukban M. E-cadherin-A surrogate marker and its relation to other biomarkers in early stages of diabetic nephropathy in eastern proving of Saudi Arabian population. J Glob Pharma Technol. 2016;8:18\u201326.","journal-title":"J Glob Pharma Technol."},{"key":"1744_CR22","first-page":"9","volume":"2017","author":"H Chen","year":"2017","unstructured":"Chen H, Xu Y, Yang Y, Zhou X, Dai S, Li C. Shenqiwan ameliorates renal fibrosis in rats by inhibiting TGF-\u03b2 1\/smads signaling pathway. Evidence Based Complement Altern Med. 2017;2017:9.","journal-title":"Evidence Based Complement Altern Med."},{"key":"1744_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/dmrr.940","volume":"25","author":"H Jiang","year":"2009","unstructured":"Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev. 2009;25:232\u201341.","journal-title":"Diabetes Metab Res Rev."},{"key":"1744_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1681\/ASN.2007050581","volume":"19","author":"C Lorz","year":"2008","unstructured":"Lorz C, Benito-Mart\u00edn A, Boucherot A, et al. The death ligand TRAIL in diabetic nephropathy. J Am Soc Nephrol. 2008;19:904\u201314.","journal-title":"J Am Soc Nephrol"},{"key":"1744_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1152\/ajprenal.2000.278.5.F847","volume":"278","author":"KT Bush","year":"2000","unstructured":"Bush KT, Tsukamoto T, Nigam SK. Selective degradation of E-cadherin and dissolution of E-cadherin-catenin complexes in epithelial ischemia. Am J Physiol Renal Physiol. 2000;278:847\u201352.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1744_CR26","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1681\/ASN.2006050525","volume":"17","author":"WC Burns","year":"2006","unstructured":"Burns WC, Twigg SM, Forbes JM, et al. Connective tissue growth factor plays an important role in advanced glycation end product\u2014induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol. 2006;17:2484\u201394.","journal-title":"J Am Soc Nephrol"},{"key":"1744_CR27","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0002-9440(10)63225-7","volume":"164","author":"JH Li","year":"2004","unstructured":"Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1\/2 MAP kinase signaling pathway. Am J Pathol. 2004;164:1389\u201397.","journal-title":"Am J Pathol"},{"key":"1744_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s40618-017-0820-x","volume":"41","author":"Y Ding","year":"2018","unstructured":"Ding Y, Ge Q, Qu H, et al. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus. J Endocrinol Invest. 2018;41:937\u201345.","journal-title":"J Endocrinol Invest"},{"key":"1744_CR29","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ajpath.2011.06.002","volume":"179","author":"K Sen","year":"2011","unstructured":"Sen K, Lindenmeyer MT, Gaspert A, et al. Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol. 2011;179:1756\u201367.","journal-title":"Am J Pathol"},{"key":"1744_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2222.2011.03840.x","volume":"42","author":"ED Gordon","year":"2012","unstructured":"Gordon ED, Sidhu SS, Wang ZE, et al. A protective role for periostin and TGF-\u03b2 in IgE-mediated allergy and airway hyperresponsiveness. Clin Exp Allergy. 2012;42:144\u201355.","journal-title":"Clin Exp Allergy"},{"key":"1744_CR31","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1681\/ASN.2013060664","volume":"25","author":"M Mael-Ainin","year":"2014","unstructured":"Mael-Ainin M, Abed A, Conway SJ, Dussaule J-C, Chatziantoniou C. Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol. 2014;25:1724\u201336.","journal-title":"J Am Soc Nephrol"},{"key":"1744_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09238-6","volume":"7","author":"JE Um","year":"2017","unstructured":"Um JE, Park JT, Nam BY, et al. Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions. Sci Rep. 2017;7:1\u201312.","journal-title":"Sci Rep"},{"key":"1744_CR33","doi-asserted-by":"publisher","first-page":"e31974","DOI":"10.1371\/journal.pone.0031974","volume":"7","author":"D Guerrot","year":"2012","unstructured":"Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, et al. Identification of periostin as a critical marker of progression\/reversal of hypertensive nephropathy. PLoS One. 2012;7:e31974.","journal-title":"PLoS One"},{"key":"1744_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.transproceed.2013.07.069","volume":"46","author":"B Satirapoj","year":"2014","unstructured":"Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P. Urine periostin as a biomarker of renal injury in chronic allograft nephropathy. Transplant Proc. 2014;46:135\u201340.","journal-title":"Transplant Proc"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-019-01744-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-019-01744-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T23:30:02Z","timestamp":1589671802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-019-01744-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,18]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1744"],"URL":"https:\/\/doi.org\/10.1007\/s10157-019-01744-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,18]]},"assertion":[{"value":"24 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Human Ethical Review Committee, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt, and the NIDE, Cairo, Egypt at which the studies were conducted (Approval number 122\/2015) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}